Core Viewpoint - Qizheng Tibetan Medicine (002287.SZ) has received approval from the Macao SAR Government's Drug Regulatory Authority for the registration of its traditional Chinese medicine product, "Cui Tang Granules" [1] Group 1: Company Developments - Qizheng's wholly-owned subsidiary, Qizheng (Macao) International Limited, is responsible for the newly approved product [1] - The product, Cui Tang Granules, is based on a Tibetan prescription dating back to the 15th century [1] Group 2: Product Information - Cui Tang Granules are indicated for respiratory system ailments, particularly for treating symptoms associated with the common cold [1] - The main functions of Cui Tang Granules include clearing heat and relieving exterior symptoms, as well as alleviating cough and pain [1] - The product is used for initial symptoms of colds, coughs, headaches, and joint pain, and is also aimed at preventing and treating influenza [1]
奇正藏药(002287.SZ):催汤颗粒获得澳门中成药注册证明书